Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
- HC Wainwright & Co. raised Cytokinetics, Incorporated (NASDAQ: CYTK) price target from $49 to $58. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. Cytokinetics shares fell 4.3% to close at $32.81 on Thursday. See how other analysts view this stock.
- DA Davidson increased the price target for WD-40 Company (NASDAQ: WDFC) from $256 to $258. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating. WD-40 shares fell 0.9% to close at $204.22 on Thursday. See how other analysts view this stock.
- Citigroup lowered Teladoc Health, Inc. (NYSE: TDOC) price target from $29 to $21. Citigroup analyst Daniel Grosslight maintained a Neutral rating. Teladoc Health shares fell 0.3% to $18.10 ...